Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

December 2030 94

  1. Study completion Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05155137

  2. Study completion Effect of Neuromuscular Electrical Stimulation on Unilateral Central Facial Palsy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07325604

  3. Primary completion Effect of Neuromuscular Electrical Stimulation on Unilateral Central Facial Palsy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07325604

  4. Primary completion Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07022587

  5. Study completion Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05797519

  6. Study completion Feasibility and Cost of Robot-assisted Upper Limb Rehabilitation With Different Levels of Supervision Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06725784

  7. Primary completion Feasibility and Cost of Robot-assisted Upper Limb Rehabilitation With Different Levels of Supervision Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06725784

  8. Study completion Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07632898

  9. Study completion Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral Anticoagulation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07739888

  10. Primary completion Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral Anticoagulation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07739888

  11. Study completion Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07770282

  12. Primary completion Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina Class 3-4 Who Are Not Candidates for Revascularization Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01566175

  13. Study completion The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03142152

  14. Study completion Bimanual Motor Skill Learning Through Robotics in Stroke Survivors and Healthy Individuals Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03974750

  15. Primary completion Bimanual Motor Skill Learning Through Robotics in Stroke Survivors and Healthy Individuals Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03974750

  16. Study completion B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04747626

  17. Primary completion B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04747626

  18. Study completion Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04798768

  19. Study completion Scandinavian Trial of Uncomplicated Aortic Dissection Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05215587

  20. Study completion Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05598333

  21. Study completion Improving Stroke Care in North-Norway Through Artificial Intelligence Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05903898

  22. Study completion The HEARTFELT Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06222099

  23. Study completion EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06249945

  24. Study completion ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06320431

  25. Study completion Cerebrolysin After Reperfusion in Extended-window EndoVascular Thrombectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06339411

  26. Study completion The Effect of Continuous Glucose Monitoring in Individuals With Newly Diagnosed Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06471699

  27. Study completion A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06642623

  28. Study completion Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06900725

  29. Primary completion Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06900725

  30. Primary completion Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07052799

  31. Study completion PRECISION-CPR: PRecision-Controlled Ventilation in CPR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07088120

  32. Study completion Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07210606

  33. Study completion A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07227532

  34. Primary completion A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07227532

  35. Primary completion Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07288749

  36. Study completion Gravity Stroke System for Recanalization of Large Vessel Occlusion Strokes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07335185

  37. Study completion Relaxin Therapy for Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07359872

  38. Primary completion Relaxin Therapy for Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07359872

  39. Study completion Retrograde Ascending Dissection: Intraluminal Aortic Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07405242

  40. Study completion Comparison of Tunneled Cuffed Dialysis Catheters Versus Arteriovenous Fistulae in Elderly or Multimorbid Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07649083

  41. Primary completion ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07687056

  42. Study completion Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07797036

  43. Study completion Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07806279

  44. Primary completion Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07806279

  45. Study completion A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07821957

  46. Study completion Combined Antiplatelet Strategy in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPRIME) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07844603

  47. Primary completion Combined Antiplatelet Strategy in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPRIME) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07844603

  48. Study completion Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07852637

  49. Primary completion INTRA-ARTERIAL MeVO TREATMENT (IMP-ACT) Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07906275

January 2031 12

  1. Study completion Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07257198

  2. Primary completion TRI-SUCCESS - Tricuspid Regurgitation Study of the Unica™ Cross-Caval System for the Evaluation of Efficacy and Safety in Significant TR Subjects Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07919366

  3. Study completion Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04700826

  4. Study completion Incremental Hemodialysis: The TwoPlus Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05828823

  5. Primary completion Comparisons of Metabolic Effect of Sleeve Gastrectomy With Duodenojejunal Bypass and Sleeve Gastrectomy (MEDUSA): A Multicenter Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05211375

  6. Study completion Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05949281

  7. Primary completion Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05949281

  8. Primary completion An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07234032

  9. Study completion Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06872684

  10. Study completion Diabetes Prevention Through Genetics, Familial History and Behavior Change Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07815236

  11. Primary completion Diabetes Prevention Through Genetics, Familial History and Behavior Change Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07815236

February 2031 7

  1. Study completion inDividual, Targeted thrombosIS Prophylaxis Versus the Standard One Size Fits All Approach in Patients Undergoing Total hIp or Total kNee replaCemenT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06581965

  2. Study completion Prevail Global Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06535854

  3. Study completion Pivotal Study of the Silk Vista Baby Flow Diverters in the Treatment of Unruptured Intracranial Aneurysms (PIONEER) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07225075

  4. Study completion Obstructive Sleep Apnea Treatment From Acute to Chronic Phase of Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07044830

  5. Study completion Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE II) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07343076

  6. Primary completion Combined Mitral and Tricuspid Versus Isolated Mitral Transcatheter Edge-to-Edge Repair for Mitral Regurgitation With Tricuspid Regurgitation (DUAL-TEER Trial) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07349888

  7. Study completion Metformin in Acute Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07899307

March 2031 14

  1. Study completion Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03323476

  2. Study completion RESPONDER-HF Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05425459

  3. Study completion Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07157774

  4. Primary completion Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07157774

  5. Study completion BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07363161

  6. Study completion Vitamin D and Type 2 Diabetes - Treat-To-Target Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07448974

  7. Study completion Selenium Intervention Registry Randomized Trial in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07543562

  8. Study completion Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04746677

  9. Primary completion Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04746677

  10. Study completion Gathering Evidence on Best Practices for Lay Rescuer CPR Training Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05908500

  11. Primary completion Statins to Prevent Cancer Associated Blood Clots Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07303816

  12. Study completion ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07687056

  13. Study completion Testing Heart Failure Resilience Intervention for Caregivers (HEROIC) in Advanced Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07805811

  14. Study completion INTRA-ARTERIAL MeVO TREATMENT (IMP-ACT) Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07906275

April 2031 9

  1. Study completion Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07090343

  2. Study completion Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07460505

  3. Primary completion Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07460505

  4. Study completion Amplatzer Amulet LAAO vs. NOAC Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04226547

  5. Study completion DIALysis With EXpanded Solute Removal Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06660277

  6. Primary completion DIALysis With EXpanded Solute Removal Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06660277

  7. Primary completion Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07478003

  8. Primary completion Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07611747

  9. Study completion De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05213676

May 2031 10

  1. Study completion Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05378347

  2. Study completion Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06930885

  3. Primary completion Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06930885

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Primary completion Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI Registry record

    Expected 2026-05-22; that period ended on 2026-05-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04951856

  2. Study completion The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation Registry record

    Expected 2026-05-28; that period ended on 2026-05-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07314047

  3. Study completion Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF) Registry record

    Expected 2026-05-29; that period ended on 2026-05-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05172765

  4. Study start A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional Limitations Registry record

    Expected 2026-05-29; that period ended on 2026-05-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07612657

  5. Primary completion Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age Registry record

    Expected 2026-05-30; that period ended on 2026-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06250257

  6. Study completion Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke Registry record

    Expected 2026-05-30; that period ended on 2026-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06358313

  7. Primary completion Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients Registry record

    Expected 2026-05-30; that period ended on 2026-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06417489

  8. Primary completion Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism Registry record

    Expected 2026-05-30; that period ended on 2026-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06773663

  9. Study completion 3-Dimensional Simulation Guided Transcatheter Aortic Valve Replacement in Aortic Regurgitation(DIGITAL) Registry record

    Expected 2026-05-30; that period ended on 2026-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07398911

  10. Primary completion 3-Dimensional Simulation Guided Transcatheter Aortic Valve Replacement in Aortic Regurgitation(DIGITAL) Registry record

    Expected 2026-05-30; that period ended on 2026-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07398911

  11. Primary completion Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention Registry record

    Expected 2026-05-30; that period ended on 2026-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07536802

  12. Study completion The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin:Comparing With Standardized Statin Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02726555

  13. Primary completion The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin:Comparing With Standardized Statin Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02726555

  14. Study completion TARGET BP I Clinical Trial Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02910414

  15. Primary completion SyncAV Post-Market Trial Registry record

    Expected 2026-05-31; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04100148

  16. Primary completion Mi-thos® Transcatheter Mitral Valve Replacement Study Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04195984

  17. Primary completion Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia. Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04602754

  18. Primary completion US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary Embolism Registry record

    Expected 2026-05-31; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05127915

  19. Study completion Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET) Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05182970

  20. Primary completion Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET) Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05182970

  21. Primary completion Hybrid Ablation of Atrial Fibrillation in Heart Failure Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05411614

  22. Primary completion Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis Registry record

    Expected 2026-05-31; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05644314

  23. Study completion Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05708859

  24. Primary completion The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05719376

  25. Study completion Impact of Obstructive Sleep Apnea (OSA) Treatment on Blood Pressure Control in Chronic Kidney Disease Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05846490

  26. Study completion Innovative Approaches for Personalised Cardiovascular Prevention Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05883878

  27. Primary completion Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05886088

  28. Study completion Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05893498

  29. Primary completion Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05893498

  30. Primary completion Shock Energy for Electrical Cardioversion of Persistent Atrial Fibrillation Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05903170

  31. Primary completion Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05999851

  32. Study completion Effect of Dexamethason on Postimplantation Syndrome After EVAR Registry record

    Expected 2026-05-31; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06044480

  33. Study completion Evaluation of the Efficacy and Safety of Surgical Device Lymphoblock for Prevention of Lymphorrhea in Patients With Thoracoabdominal Aorta Repair. Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06286540

  34. Study completion Cardiac Interventional ICE Imaging Trial Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06344494

  35. Study completion Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP and Prox BTK-Lesions (JETART) Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06434779

  36. Primary completion Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP and Prox BTK-Lesions (JETART) Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06434779

  37. Study completion Bingo Drug-eluting Balloon Versus a Drug-eluting Stent for Coronary Bifurcation Lesions Registry record

    Expected 2026-05-31; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06441539

  38. Study completion A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06568471

  39. Study completion AggRegated System Of sensOrs and Multimedia Monitors: Technology for innovAtion and personalizaTion of rEhabilitation Care. (ROOMMATE) Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06728020

  40. Primary completion AggRegated System Of sensOrs and Multimedia Monitors: Technology for innovAtion and personalizaTion of rEhabilitation Care. (ROOMMATE) Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06728020

  41. Study completion A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07018453

  42. Study completion Intranasal Dexmedetomidine on Blood Pressure in Elderly Hypertensive Patients Undergoing Cataract Surgery Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07080229

  43. Primary completion Nudge-Based Shared Decision Making and Self-Management in Type 2 Diabetes: A Randomized Trial Registry record

    Expected 2026-05-31; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07129915

  44. Primary completion The Clinical Application of Peripheral Embolization Coil Systems in Arteriovenous Embolization Within the Peripheral Vasculature Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07156409

  45. Primary completion Evaluation of a Single-lead ECG Patch-based Telemetry System for In-hospital Monitoring Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07260721

  46. Primary completion The Coronary Sinus Balloon Pump in STEMI Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07354035

  47. Primary completion Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes Mellitus Registry record

    Expected 2026-05-31; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07374328

  48. Study start Neurophysiological Markers for Prediction of Rehabilitation Outcomes After Ischemic Stroke Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07520630

  49. Study start Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney Disease Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07537088

  50. Study start Evaluation of Accelerated Bachmann Bundle Area Pacing in Heart Failure With Reduced ejectIon Fraction Who Have electrocarDioGraphic Evidence of Interatrial Block and Indicated for Implantable Cardioverter Defibrillator Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07547306

  51. Study start 1 or 6 Months of Dual Antiplatelet Therapy After Drug-coated Balloon Angioplasty for De-novo Small Coronary Artery Disease Registry record

    Expected 2026-05; that period ended on 2026-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07592507

  52. Primary completion ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04503395

  53. Study completion Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Upper Extremity Motor Function in Stroke Patients Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05646134

  54. Primary completion Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis. Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05933720

  55. Study completion Verify Effectiveness and Safety of Paclitaxel-Coated Coronary Balloon Catheters Swide® Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06024525

  56. Study completion Bioabsorbable/Nufairy Coil Application Trial in China Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06466564

  57. Study completion PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG) Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06542393

  58. Study completion Study of Tiprogrel in the Treatment of High-risk Patients with Acute Ischemic Cerebrovascular Events (THRIVE). Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06601127

  59. Primary completion SONICURE(SONICracker for the Treatment of UndeRExpansion) Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06924736

  60. Primary completion The Application of Positive End-Expiratory Pressure in Out-of-Hospital Cardiac Arrest: The Lazarus-PEEP Trial. Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06939335

  61. Primary completion Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN) Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07018557

  62. Primary completion Development and Validation of a Comprehensive Management Service Package for Older Adults With Multimorbidity Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07151430

  63. Study start Design and Rationale of the COLT Study Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07432529

  64. Study completion Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07436182

  65. Primary completion Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07436182

  66. Study start Spatiotemporal Evolution of Traditional Chinese Medicine Mechanisms in Acute Ischemic Stroke Treated With Dengzhan Xixin and Dengzhan Shengmai Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07591883

  67. Study start Cerebral Microembolization During Pulmonary Vein Isolation: Comparison of Different Pulsed Field Ablation Systems Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07610018

  68. Study start Pro-urokinase for Extended-Window Posterior Circulation Stroke Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07617870

  69. Study start Early Prophylactic Aspirin for Aneurysmal Subarachnoid Hemorrhage Registry record

    Expected 2026-06-01; that period ended on 2026-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07642427

  70. Study completion Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial) Registry record

    Expected 2026-06-02; that period ended on 2026-06-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05321875

  71. Primary completion Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial) Registry record

    Expected 2026-06-02; that period ended on 2026-06-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05321875

  72. Study start Stenting Versus Drug Eluting Balloons Only in Treatment of Coronary Bifurcation Lesion (ROBUST Study) Registry record

    Expected 2026-06-02; that period ended on 2026-06-02.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07552194

  73. Primary completion Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects Registry record

    Expected 2026-06-03; that period ended on 2026-06-03.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06471543

  74. Study completion Cerebral Autoregulation Guiding Blood Pressure Management After Revascularization Registry record

    Expected 2026-06-04; that period ended on 2026-06-04.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05670028

  75. Study start Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke Unit Registry record

    Expected 2026-06-08; that period ended on 2026-06-08.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07670065

  76. Study completion LEft Bundle branchArea Pacing to Avoid Pacing-induced CARdiomyopathy Registry record

    Expected 2026-06-10; that period ended on 2026-06-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05910866

  77. Study completion Performing a Low-dose, Whole-body Angiography as the First Element of an Imaging Assessment Following Stroke / TIA Registry record

    Expected 2026-06-12; that period ended on 2026-06-12.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02662751

  78. Primary completion Performing a Low-dose, Whole-body Angiography as the First Element of an Imaging Assessment Following Stroke / TIA Registry record

    Expected 2026-06-12; that period ended on 2026-06-12.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02662751

  79. Primary completion The COLchicine and Atrial FIBrillation Trial Registry record

    Expected 2026-06-14; that period ended on 2026-06-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05928728

  80. Primary completion POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy Registry record

    Expected 2026-06-15; that period ended on 2026-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05926271

  81. Study completion Empagliflozin for No-reflow Phenomenon in PCI for STEMI Registry record

    Expected 2026-06-15; that period ended on 2026-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06342141

  82. Primary completion Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm Registry record

    Expected 2026-06-15; that period ended on 2026-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06432452

  83. Study start Neuroprotection in Acute Cerebral Ischemia II Registry record

    Expected 2026-06-15; that period ended on 2026-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07552818

  84. Study start Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In Patients With A Large Ischemic Stroke: A Multicenter Randomized Controlled Trial (IVT-ALL-IN) Registry record

    Expected 2026-06-15; that period ended on 2026-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07603440

  85. Study start GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial Registry record

    Expected 2026-06-15; that period ended on 2026-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07613437

  86. Study start Gastric Feeding for the Prevention of Stroke-Associated Pneumonia Registry record

    Expected 2026-06-15; that period ended on 2026-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07630090

  87. Study start A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Chronic Kidney Disease Registry record

    Expected 2026-06-15; that period ended on 2026-06-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07647133

  88. Study completion Combination of Hypothermia and Thrombectomy in Acute Stroke Registry record

    Expected 2026-06-18; that period ended on 2026-06-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06301412

  89. Study completion To Evaluate the Safety and Efficacy of Intracranial Stent Assisted Endovascular Treatment of Intracranial Aneurysms Registry record

    Expected 2026-06-20; that period ended on 2026-06-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06158087

  90. Primary completion A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China Registry record

    Expected 2026-06-20; that period ended on 2026-06-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06933472

  91. Study start Efficacy and Mechanism of Yanjiu Needle for Pharyngeal Dysphagia Based on sEMG Features Registry record

    Expected 2026-06-20; that period ended on 2026-06-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07656025

  92. Study start Apixaban Versus Warfarin for Left Ventricular Thrombus Registry record

    Expected 2026-06-22; that period ended on 2026-06-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07709780

  93. Study completion VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication. Registry record

    Expected 2026-06-24; that period ended on 2026-06-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03686306

  94. Primary completion REmote COnditioning in Out-of-Hospital Cardiac Arrest Registry record

    Expected 2026-06-24; that period ended on 2026-06-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06306625

  95. Study start STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump Registry record

    Expected 2026-06-25; that period ended on 2026-06-25.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07644247

  96. Study start Digital Screening for Atrial Fibrillation to Prevent Stroke Registry record

    Expected 2026-06-29; that period ended on 2026-06-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07684053

  97. Study completion The OCT SORT-OUT VIII Study Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02253108

  98. Study completion Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02347111

  99. Primary completion Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation Registry record

    Expected 2026-06-30; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02347111

  100. Study completion Controlling and Lowering Blood Pressure With the MobiusHD™ Registry record

    Expected 2026-06; that period ended on 2026-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02827032